BACE1 and Alzheimer disease: Serum activity of BACE1 was different between groups, being 60.67% higher in AD + MCI-AD than in CTRL [mean±SD: CTRL, 7.626±1.877; AD +MCI-AD, 19.390±14.020; p < 0.001] (Table 2; Fig. 1A).